BY NIKOLA STIKOV
In May 2016, OHBM announced the Open Science Special Interest Group (SIG). One of the SIG founders, Cameron Craddock, wrote an informative blog post about the mission of SIG and its potential. In the post Cameron illustrated the benefits and distinctions of open science by drawing upon the free beer vs. free speech analogy. The OHBM blog team felt that ‘beer vs. speech’ is jargon that needs explaining. Twitter thought otherwise. This made us aware that the open science voices are sometimes difficult to hear outside of their own echo chamber, especially in the noisy world of brain mapping. Cameron removed the reference to speech/beer from his feature, and we agreed to pick up the conversation with Samir Das and Pierre Bellec, two free speech and beer enthusiasts from Montreal.
BY THE KOREAN SOCIETY FOR HUMAN BRAIN MAPPING
The function and anatomy of the human brain are the basis of debates related to the inner workings of the human mind and body. Before the arrival of brain imaging technology, ethical dilemmas hindered neuroscientists who wished to conduct scientific studies on humans. Fortunately, neuroimaging techniques such as MRI, PET and SPECT have opened a new chapter in brain mapping. With the opening of “A New Window into the Human Brain” as Victor H. Fischer argued in 1962, researchers have been able to investigate not only human brain physiology and connectivity, but also its functionality, such as emotion and cognition, as well as numerous mental health disorders.
To keep pace with this emerging field of research, South Korea started its first society of brain imaging researchers, the Korean Society for Human Brain Mapping, or KHBM, in 2002. Given that modern human brain mapping utilizes cutting edge information technology (IT), the rapid development of the IT industry in Korea facilitated the early development of the KHBM. The Korean government promoted research and development in the IT industry early on in order to increase Korea’s share of the international information and communication technology market. This timely advance allowed for a positive feedback loop, in which the investment strategy in a variety of IT fields enhanced prompt industrial growth. In 2013, the Korean IT industry alone represented 30.9% of manufactured industrial products, as measured by the Gross Domestic Product (GDP), in comparison to 13.6% in 1997. At the same time, the biotechnology industry increased its share of the GDP by a factor of 12.7, from ₩0.59 trillion in 1997 to ₩7.51 trillion in 2013. Such statistics clearly illustrate the rise in the importance of medical technology in Korea.